Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung-Reference-Cited by-同舟云学术

Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung

Published:2021-08-28 Issue:20 Volume:12 Page:2666-2679
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Ohtaki Yoichi¹^ORCID,Kaira Kyoichi²^ORCID,Yajima Toshiki¹³^ORCID,Erkhem‐Ochir Bilguun¹,Kawashima Osamu⁴,Kamiyoshihara Mitsuhiro⁵^ORCID,Igai Hitoshi⁵^ORCID,Onozato Ryoichi⁶^ORCID,Ibe Takashi⁷,Kosaka Takayuki⁷,Nakazawa Seshiru¹^ORCID,Nagashima Toshiteru¹⁶,Oyama Tetsunari⁸^ORCID,Shirabe Ken¹

Affiliation:

1. Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Department of General Surgical Science Gunma University Graduate School of Medicine Maebashi Japan

2. Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center Saitama Medical University Saitama Japan

3. Department of Innovative Cancer Immunotherapy Gunma University Graduate School of Medicine Maebashi Japan

4. Department of General Thoracic Surgery National Hospital Organization Shibukawa Medical Center Shibukawa Japan

5. Department of General Thoracic Surgery Maebashi Red Cross Hospital Maebashi Japan

6. Department of General Thoracic Surgery Gunma Prefectural Cancer Center Ota Japan

7. Department of General Thoracic Surgery National Hospital Organization Takasaki General Medical Center Takasaki Japan

8. Department of Diagnostic Pathology Gunma University Graduate School of Medicine Maebashi Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14102

Reference39 articles.

1. Thoracic and cardiovascular surgeries in Japan during 2017

2. Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy

3. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung

4. Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)

5. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLC;Oncology Reports;2022-10-20

2. Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer;Cancer Science;2022-07-18

3. An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma;Frontiers in Oncology;2022-07-01

4. Carcinomes neuroendocrines à grandes cellules (CNEGC) métastatiques et immunothérapie : actualités 2022;Revue des Maladies Respiratoires Actualités;2022-05